Clinical trial
Effects of Cardioprotective Therapy, Carvedilol vs Ramipril, in Patients Affected by Duchenne and Becker Muscular Dystrophy. Clinical Significance and Prognostic Value of Cardiac Magnetic Resonance Study.
NCT00819845 is registered in ClinicalTrials.gov with Catholic University, Italy as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Cardioprotective Therapy, Carvedilol vs Ramipril, in Patients Affected by Duchenne and Becker Muscular Dystrophy. Clinical Significance and Prognostic Value of Cardiac Magnetic Resonance Study.
- Lead sponsor
- Catholic University, Italy
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- December 31, 2008
- Completion date
- December 31, 2016
- Enrollment
- 194 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
becker muscular dystrophy, duchenne muscular dystrophy